Cochlear Implant With Anti-Inflammatory Agent

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 10, 2013

Primary Completion Date

November 6, 2017

Study Completion Date

March 15, 2018

Conditions
Hearing Loss
Interventions
DEVICE

Contour Advance electrode with controlled dose of dexamethasone base

The Combined Device consists of a standard cochlear implant receiver-stimulator coupled to a Contour Advance electrode loaded with a controlled dose of dexamethasone base.

DEVICE

Contour Advance electrode

Standard Contour Advance electrode

Trial Locations (1)

3053

The HEARing CRC, Melbourne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cochlear

INDUSTRY

collaborator

Royal Victoria Eye and Ear Hospital

OTHER_GOV

collaborator

Royal Prince Alfred Hospital, Sydney, Australia

OTHER

collaborator

St Vincent's Hospital Melbourne

OTHER

collaborator

Westmead Hospital, New South Wales

UNKNOWN

lead

The Hearing Cooperative Research Centre

OTHER

NCT02905305 - Cochlear Implant With Anti-Inflammatory Agent | Biotech Hunter | Biotech Hunter